Letter/Comment
The latest advocacy letters and comments from the American Hospital Association.
AHA's comments to the Office of the National Coordinator for Health Information Technology, expressing strong support for creating a useable, scalable and efficient solution to help reduce prior authorization impacts on patients and providers.
On behalf of our nearly 5,000 member hospitals, health systems and other health care organizations, our clinician partners — including more than 270,000 affiliated physicians, 2 million nurses and other caregivers — and the 43,000 health care leaders who belong to our professional membership groups…
The AHA and FAH urge CMS to deny DHR’s request for an exception to the prohibition on expansion of the facility capacity of a physician-owned hospital. CMS is not obligated by statute or regulation to grant an expansion request to any facility that satisfies the “high Medicaid facility” exception…
AHA expresses support the Hospital Inpatient Services Modernization Act (S. 3792).
The AHA expresses support for the Hospital Inpatient Services Modernization Act, bipartisan legislation that would extend the Centers for Medicare & Medicaid Services’ acute hospital care at home waiver program two years beyond the end of the COVID-19 public health emergency.
AHA encourages the Centers for Medicare & Medicaid Services to work with Congress to require Medicare Advantage plans to waive prior authorization and other utilization management policies during public health emergencies, especially for hospitals transferring patients to post-acute care.
Responding to a request for information on digital health, the AHA March 4th urged Congress to permanently eliminate all restrictions on telehealth originating and geographic sites; continue to allow rural health clinics and federally qualified health centers to serve as distant sites for all…
: Letter with comments to CMS on the burden estimates associated with the delivery of good faith estimates to uninsured and self-pay patients and the patient-provider dispute resolution process established under the No Surprises Act.
AHA urges HHS to ensure hospitals participating in the 340B Drug Pricing Program do not lose access to the program as a result of changes in patterns of patient care due to the COVID-19 public health emergency (PHE).